Multi-ancestry PRS Allelica specializes in clinically validated, multi-ancestry polygenic risk score testing, offering clear upsell potential to labs, hospitals, and biopharma seeking comprehensive risk assessment tools across diverse populations.

Strategic partnerships Recent collaborations with Mass General Brigham, Veterans Affairs, and Cleerly indicate a strong channel strategy with major health systems and public sector programs, presenting opportunities to expand shared PRS capabilities and large-scale trials.

CLIA on-premises Allelica provides on-premises CLIA‑compliant solutions via Precision Server and AbsoluteDx, enabling labs to operationalize PRS with regulatory rigor, a compelling option for institutions prioritizing data sovereignty and validated workflows.

Clinical trial enablement With PROACT 3 collaboration and genomics-informed care initiatives for veterans, there is a clear sales path to contract with research networks and government or veteran health programs seeking genomics-enabled prevention strategies.

Broad institutional validation Publication in Circulation and Nature Communications and deployments across leading healthcare institutions signal credibility; use this for pitches emphasizing quality, regulatory compliance, and evidence-backed risk stratification to win large enterprise customers.